ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials

NEXT STORY
Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors
PREV STORY
India Disposable Syringes Markets, 2021-2026 by Type, Pre-filled Syringes, Safety Syringes, Application, End User, Material
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mustang Bio Announces Appointment of Manuel Litchman, M.D., as President and Chief Executive Officer

NEW YORK, April 24, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”), a Fortress ...

author_avatar
NASDAQ Market News

Ziopharm Oncology Granted Rare Pediatric Disease Designation for Controlled IL-12 for the Treatment of DIPG

author_avatar
NASDAQ Market News

Precision Therapeutics Inc. is Excited to Announce a Special Meeting of Stockholders and Commencement of Registered Exchange Offer

author_avatar
NASDAQ Market News